## Abstract Overexpression of Pβglycoprotein (Pβgp) has been identified by a variety of methods in NK cells and NK malignancies. The aim of this study was to determine the clinical significance of Pβgp in previously untreated extranodal NK/Tβcell lymphoma, nasal type. Tumor specimens from 30 patien
Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells
β Scribed by Motoko Yamaguchi; Kenkichi Kita; Hiroshi Miwa; Kazuhiro Nishii; Kouji Oka; Toshiyuki Ohno; Shigeru Shirakawa; Manabu Fukumoto
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 554 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Metastatic malignant melanoma is considered a chemotherapy-refractory malignancy. A few previous studies have delivered contradictory results regarding the presence and functionality of P-glycoprotein (P-gp), a transmembranous protein associated with the classical multidrug resistance (cMDR), in mal
Expression of the MDR I (P-glycoprotein) gene confers resistance to several classes of chemotherapeutic drugs (multi-drug resistance). Colon carcinomas frequently express high levels of MDR I mRNA and P-glycoprotein, presumably reflecting the origin of these tumors from MDRl -expressing normal colon
## Abstract Using variants of the murine BW5147 lymphoma cellβline, we have previously identified 3 monoclonal antibodies (MAbs) that discriminate between metastatic and nonmetastatic BW5147βderived Tβcell hybridomas and lymphomas, as well as BW5147βunrelated Tβlymphomas. These MAbs were reported t